XIST promotes gastric cancer (GC) progression through TGF-β1 via targeting miR-185. Quan Zhang et al, 2018, J Cell Biochem CrossRef
GPCRs: Emerging anti-cancer drug targets Ainhoa Nieto Gutierrez et al, 2017, Cellular Signalling CrossRef
Kindlins: Roles in development and cancer progression Jun Zhan et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression Wen-Shih Huang et al, 2018, J. Cell. Biochem. CrossRef
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells Dauren Alimbetov et al, 2018, IJMS CrossRef
Drug resistance and new therapies in colorectal cancer. Kevin Van der Jeught et al, 2018, World J Gastroenterol CrossRef
Role of the transforming growth factor‐β signaling pathway in the pathogenesis of colorectal cancer Atena Soleimani et al, 2018, J Cell Biochem CrossRef
Proteomic investigations into resistance in colorectal cancer David I. Cantor et al, 2020, Expert Review of Proteomics CrossRef
Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer Xuanxuan Yang et al, 2020, Medicine CrossRef
Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis Robert Beaumont Wilson, 2018 CrossRef
Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition Robert B. Wilson et al, 2020, IJMS CrossRef
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors Vincenzo Formica et al, 2020, Targ Oncol CrossRef
Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways Zhi-Ping Zhou et al, 2018, Int J Oncol CrossRef
The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis. Fangfang Sun et al, 2019, Mol Med Rep CrossRef
TGF-β1 protects colon tumor cells from apoptosis through�XAF1 suppression Jung Rock Moon et al, 2019, Int J Oncol CrossRef
MicroRNA‑124 regulates TRAF6 expression and functions as an independent prognostic factor in colorectal cancer Chen Wei et al, 2019, Oncol Lett CrossRef
Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer Ming Bai et al, 2020, J Physiol Biochem CrossRef
DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer. Jinyu Zhang et al, 2020, Front Pharmacol CrossRef
CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway
Development of Pharyngocutaneous Fistula after Total Laryngectomy: The Predictive Value of C-reactive Protein/Albumin Ratio Abitter Yücel et al, 2020, Acta Med. (Hradec Kralove, Czech Repub.) CrossRef
LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes Duilia Brex et al, 2021, Front. Oncol. CrossRef
Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer Carolina Mendonça Gorgulho et al, 2021 CrossRef
Drug Resistance Mechanisms on Colorectal Cancer Hasan KURTER et al, 2021 CrossRef
SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy Zuzana Ezrova et al, 2021, Oncogene CrossRef
TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance Flaviana Marzano et al, 2021, Biomedicines CrossRef
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer Isaac Micallef et al, 2021, ncRNA CrossRef
BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells Yuan Zhang et al, 2021, IJMS CrossRef
Cancer drug resistance induced by EMT: novel therapeutic strategies Javier De Las Rivas et al, 2021, Arch Toxicol CrossRef
Clinical significance and prognostic value of C-reactive protein/albumin ratio in gastric cancer Qian Yu et al, 2021, Ann Surg Treat Res CrossRef
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment. Jeff Yat-Fai Chung et al, 2021, Int J Mol Sci CrossRef
Reducing tumor invasiveness by ramucirumab and TGF‐β receptor kinase inhibitor in a diffuse‐type gastric cancer patient‐derived cell model Song‐Yi Lee et al, 2021, Cancer Med CrossRef
Neutrophil-to-lymphocyte ratio and C-reactive protein–to–albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer Tsutomu Namikawa et al, 2021, Langenbecks Arch Surg CrossRef
Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids Venkanagouda S. Goudar et al, 2021, ACS Appl. Mater. Interfaces CrossRef
Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers Xiaoqun Lv et al, 2021, WJGO CrossRef
In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor Hasan Kurter et al, 2022 CrossRef
Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1 Tsung-Wei Chen et al, 2022, Cancer Letters CrossRef
Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy Klara Mladenić et al, 2021, CCAND CrossRef
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers Tara L. Hogenson et al, 2022 CrossRef
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives Belén Toledo et al, 2022, IJMS CrossRef
“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction” Federica Papaccio et al, 2023, J Exp Clin Cancer Res CrossRef
A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases Vigdis Nygaard et al, 2023 CrossRef
Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways Eisa Sabouni et al, 2023, Biomedicine & Pharmacotherapy CrossRef
MicroRNA-185: a non-invasive diagnostic and prognostic tumor marker Faezeh Tolue Ghasaban et al, 2023, Process Biochemistry CrossRef
Colorectal cancer: epidemiology, carcinogenesis, molecular subtypes and cellular mechanisms of therapy resistance (analytical review) P. E. Maksimova et al, 2023, Koloproktologiâ CrossRef
TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer Sumeet Singh et al, 2023, Med Oncol CrossRef
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer Yini Xu et al, 2023, Molecular Carcinogenesis CrossRef
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs Peng Xing et al, 2023, Drug Resistance Updates CrossRef
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different Oxaliplatin-based HIPEC regimens Aras Emre Canda et al, 2024 CrossRef
A highly sensitive fluorescent HClO probe for discrimination between cancerous and normal cells/tissues Linfang Wang et al, 2023, Chinese Chemical Letters CrossRef